Published in Antimicrob Agents Chemother on September 01, 1993
Some repair-deficient mutants of Dictyostelium discoideum display enhanced susceptibilities to bleomycin. Antimicrob Agents Chemother (1996) 0.79
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev (1984) 19.14
Transposition of R factor genes to bacteriophage lambda. Proc Natl Acad Sci U S A (1975) 9.28
Structural analysis of Tn5. Cold Spring Harb Symp Quant Biol (1981) 6.16
The functional differences in the inverted repeats of Tn5 are caused by a single base pair nonhomology. Cell (1981) 3.46
Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother (1981) 2.78
Completion of the nucleotide sequence of the central region of Tn5 confirms the presence of three resistance genes. Nucleic Acids Res (1985) 2.31
Tn5 carries a streptomycin resistance determinant downstream from the kanamycin resistance gene. Mol Gen Genet (1983) 2.06
Interaction of bleomycin A2 with deoxyribonucleic acid: DNA unwinding and inhibition of bleomycin-induced DNA breakage by cationic thiazole amides related to bleomycin A2. Biochemistry (1985) 1.94
The transposon Tn5 carries a bleomycin-resistance determinant. Gene (1984) 1.65
The mechanism of the bleomycin-induced cleavage of DNA. Biochem Biophys Res Commun (1977) 1.44
Host-dependent transposon Tn5-mediated streptomycin resistance. J Bacteriol (1984) 1.39
High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake. Antimicrob Agents Chemother (1986) 1.25
Bleomycin-resistance gene derived from the transposon Tn5 confers selective advantage to Escherichia coli K-12. Proc Natl Acad Sci U S A (1991) 1.18
Expression of Tn5-encoded streptomycin resistance in E. coli. Mol Gen Genet (1986) 0.90
Identification of a Tn5 determinant conferring resistance to phleomycins, bleomycins, and tallysomycins. Plasmid (1985) 0.90
Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli. Antimicrob Agents Chemother (1982) 0.84
A clinical isolate of transposon Tn5 expressing streptomycin resistance in Escherichia coli. J Bacteriol (1988) 0.82
Comparative genomics of Listeria species. Science (2001) 12.94
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill (2008) 4.03
Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect (2008) 3.18
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother (2001) 2.91
Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli. J Bacteriol (1978) 2.83
Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A (2006) 2.80
Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol (1999) 2.63
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1993) 2.34
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother (1991) 2.12
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother (1995) 1.99
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS (1997) 1.98
European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect (2004) 1.95
Plasmids in Listeria. Plasmid (1982) 1.94
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol (1997) 1.72
Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother (1994) 1.71
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem (1998) 1.70
Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol (1998) 1.66
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol (2000) 1.62
Some aspects of human and canine macroscopic pancreas innervation. Am J Gastroenterol (1976) 1.57
Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother (2000) 1.55
Resistance to beta-lactam/clavulanate. Lancet (1987) 1.54
Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.53
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang (1998) 1.51
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother (2000) 1.48
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46
Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol Rev (1990) 1.44
In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents (2006) 1.42
Do bacteria have sex? Nature (1991) 1.42
beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J Antimicrob Chemother (1985) 1.40
The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother (1992) 1.40
An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett (1998) 1.40
Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob Agents Chemother (1995) 1.40
Giant magnetoresistance in ferromagnet/superconductor superlattices. Phys Rev Lett (2005) 1.39
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother (1989) 1.31
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase. Antimicrob Agents Chemother (1996) 1.30
Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis (1996) 1.29
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1996) 1.28
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. Antimicrob Agents Chemother (2000) 1.27
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25
Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother (1990) 1.25
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Soft salt-mannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1998) 1.22
A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases. Antimicrob Agents Chemother (1998) 1.22
Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1995) 1.21
Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother (2001) 1.18
A model for whiplash. J Biomech (1968) 1.18
Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis (1996) 1.17
Leptotrichia buccalis bacteremia in neutropenic children. J Clin Microbiol (1985) 1.12
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother (1998) 1.12
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob Agents Chemother (1999) 1.11
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci (1999) 1.11
In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother (1994) 1.11
Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology (Berl) (1987) 1.11
A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol Lett (2000) 1.10
Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors. Diagn Microbiol Infect Dis (1996) 1.09
H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. J Bacteriol (1997) 1.09
Improved method of determining the susceptibility of Candida albicans to fluconazole. J Antimicrob Chemother (1995) 1.08
Vancomycin-resistant enterococci isolated from animals and food. Int J Food Microbiol (2000) 1.08
Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrob Agents Chemother (2000) 1.08
Aerobactin production as a virulence factor: a reevaluation. Eur J Clin Microbiol Infect Dis (1988) 1.08
Modulation of DNA topology by flaR, a new gene from Listeria monocytogenes. Mol Microbiol (1995) 1.07
Ecology and evolution of antibiotic resistance. Environ Microbiol Rep (2009) 1.05
Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J Antimicrob Chemother (2002) 1.05
Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrob Agents Chemother (2001) 1.05
Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother (2001) 1.04
Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother (1999) 1.04
Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg Infect Dis (2001) 1.04
Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis (2001) 1.03
Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol (2002) 1.02
Sex chromosome linkage of 5S rDNA in rainbow trout (Oncorhynchus mykiss). Cytogenet Cell Genet (1996) 1.02
Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species. Antimicrob Agents Chemother (1987) 1.01
Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect (2006) 1.01
Cloning of two possible haemolysin determinants from Listeria monocytogenes. Ann Inst Pasteur Microbiol (1987) 1.01
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrob Agents Chemother (1999) 0.99